Instituto Oncologico Dr. Rosell

Barcelona 08028

0 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer

Studies at this site

• A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer — Stopped early